Je. Babensee et Mv. Sefton, Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response, TISSUE ENG, 6(2), 2000, pp. 165-182
Small diameter hydroxyethyl methacrylate-methyl methacrylate (HER HEMA-MMA;
75% HEMA) microcapsules containing an aggregate of viable rat hepatoma H4I
IEC3 cells, after implantation into an omental pouch in Wistar rats, contai
ned viable cells at 7 days but not 14 days. A similar transplantation of mi
croencapsulated aggregates of human hepatoma HepG2 cells did not result in
viable cells even at 7 days. The loss of viability was attributed to the ti
ssue reaction, because both encapsulated cell types remained viable in vitr
o. However, it is not clear if the cells lost their viability in vivo, lead
ing to the aggressive tissue reaction or if the latter caused the cells to
starve or otherwise die. The tissue reactions to microcapsules containing r
at or human hepatoma cells at day 1 was one cell layer thick and avascular.
At later times, tissue reactions were comprised of three regions: macropha
ges, fibroblasts, and some foreign body giant cells apposed to the polymer
membrane, a dense region of fibroblasts and collagen, and a region of vascu
larized granulation tissue. Prompt vascularization of the tissue reactions
occurred after 4 days and was maintained for up to 14 days. Even at 14 days
, immune cells were observed, suggesting a continued immune response toward
antigens shed from the encapsulated cells.